1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Diagnostic Imaging Market Trends
Cancer Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

Cancer Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

  • October 2014
  • 124 pages
  • ID: 3999248
  • Format: PDF
  • By Transparency Market Research

Summary

Table of Contents

This report on cancer diagnostics analyzes the current as well as future prospects of various facets of the market in detail. It provides an in-depth and comprehensive analysis of the cancer diagnostics market. The report includes an elaborate executive summary, which covers a market snapshot representing key findings from the study for various segments such as diagnostic methods, applications, and geography (North America, Europe, Asia-Pacific and Rest of the World).

For the research on this topic, we conducted in-depth interviews and discussions with a wide range of key opinion leaders within cancer diagnostics market, which was supplemented by extensive secondary research. The report provides market size in terms of USD million for each segment for the period 2012 to 2020, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall cancer diagnostics market and the segments has also been provided in the report for the forecast period 2014 to 2020, considering 2012 and 2013 as the base years. Growth rates for each segment within the cancer diagnostics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

The global cancer diagnostics market is categorized based on the diagnostic methods into four major segments, namely, tumor biomarker tests, imaging, endoscopy, and biopsy. The market analysis provided for tumor biomarker tests include revenue from major cancer biomarker tests such as prostate specific antigen (PSA) tests, human epidermal growth factor receptor 2 (HER2) tests, circulating tumor cells (CTC) tests , carcinoembryonic antigen (CEA) test, anaplastic lymphoma kinase (ALK) test, BRCA gene tests, and other tests such as AFP, CA 19-9, CA 125 tests. The report also provides market size for imaging procedures for cancer diagnostics, namely, magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), x-ray and ultrasound imaging. The market size estimation for endoscopies such as colonoscopy, sigmoidoscopy, bronchoscpopy and colposcopy; and biopsies such as bone marrow biopsy, needle biopsy and endoscopic biopsy are provided in the report.

The cancer diagnostics market has been further analyzed for applications such as cancer of lung, breast, colorectal, prostate, liver, blood, and others (cancers of kidney, pancreas, and ovary). According to our estimates, in 2013, lung cancer accounted for the largest share in the global cancer diagnostics market and is expected to continue to grow in the near future. On the basis of geography, the overall global cancer diagnostics market has been segmented into four major regions: North America, Europe, Asia-Pacific, and Rest of the World (ROW). The research study also incorporates a qualitative analysis of the competitive scenario in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the cancer diagnostics market and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis and Porter’s five forces analysis. In addition, the study also provides insights into the competitive landscape of the global cancer diagnostics market.

The study is a robust combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interaction via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases for patents, clinical trials, demographics, disease incidence/prevalence, etc. The report also profiles major players in the cancer diagnostics market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players covered in this report are Abbott Laboratories, Ambry Genetics, AstraZeneca plc, bioMerieux SA, Eli Lilly and Company, Genoptix (A Novartis Company), GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd. and Pfizer, Inc.

The global cancer diagnostics market is segmented as follows:

Cancer Diagnostics Market, by Method
Tumor Biomarker Tests
PSA Tests
CTC Tests
AFP Tests
CA 19-9
CA 125
EGFR
HER2
CEA
BRCA
KRAS
ALK
Imaging
MRI Scan
PET Scan
CT Scan
Mammography
Ultrasound
Endoscopy
Bronchoscopy
Colonoscopy
Sigmoidoscopy
Colposcopy
Others
Biopsy
Bone Marrow Biopsy
Needle Biopsy
Endoscopic Biopsy
Cancer Diagnostics Market, by Application
Leukemia
Breast Cancer
Colorectal Cancer
Kidney
Liver
Lung
Ovarian
Pancreatic
Prostate
Cancer Diagnostics Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

($5795)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
2020 France Cancer Diagnostics Market: Supplier Shares by Test, Competitive Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation

2020 France Cancer Diagnostics Market: Supplier Shares by Test, Competitive Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation

  • $ 3500
  • January 2020

2020 France Cancer Diagnostics Market: Supplier Shares by Test, Competitive Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest InstrumentationThis new report is a strategic analysis ...

Succeeding in the 2020 France Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

Succeeding in the 2020 France Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 3500
  • February 2020

Succeeding in the 2020 France Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and OpportunitiesThis new ...

Neurodiagnostics Market by Product, Disease Pathology, End User And Region - Global Forecast to 2024

Neurodiagnostics Market by Product, Disease Pathology, End User And Region - Global Forecast to 2024

  • $ 4950
  • December 2019

The global neurodiagnostics market is projected to grow at a CAGR of 7.3% during the forecast period.The global neurodiagnostics market is expected to reach USD 8.4 billion by 2024 from USD 5.9 billion ...


ref:plp2014

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on